Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethanol, 2-[4-(trifluoroMethoxy)phenoxy]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

627902-05-0

Post Buying Request

627902-05-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

627902-05-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 627902-05-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,7,9,0 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 627902-05:
(8*6)+(7*2)+(6*7)+(5*9)+(4*0)+(3*2)+(2*0)+(1*5)=160
160 % 10 = 0
So 627902-05-0 is a valid CAS Registry Number.

627902-05-0Relevant articles and documents

SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF

-

Page/Page column 369; 425, (2014/09/29)

Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold

Jia, Jian-Min,Liu, Fang,Xu, Xiao-Li,Guo, Xiao-Ke,Jiang, Fen,Cherfaoui, Bahidja,Sun, Hao-Peng,You, Qi-Dong

supporting information, p. 1557 - 1561 (2014/03/21)

Previously, we identified 1-(2-(4-bromophenoxy)ethoxy)-3-(4-(2- methoxyphenyl)piperazin-1-yl)propan-2-ol (1) as a novel Hsp90 inhibitor with moderate activity through virtual screening. In this study, we report the optimization process of 1. A series of analogues containing the 1-phenylpiperazine core scaffold were synthesized and evaluated. The structure-activity relationships (SAR) for these compounds was also discussed for further molecular design. This effort afforded the most active inhibitor 13f with improved activity in not only target-based level, but also cell-based level compared with the original hit 1.

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

-

Page/Page column 35, (2013/03/26)

The present invention is directed to compounds of formula I and la: which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 627902-05-0